These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4832304)

  • 1. Cyclic thrombocytopenia: a thrombopoietin deficiency?
    Lewis ML
    J Clin Pathol; 1974 Mar; 27(3):242-6. PubMed ID: 4832304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two patterns of thrombopoietin signaling suggest no coupling between platelet production and thrombopoietin reactivity in thrombocytopenia-absent radii syndrome.
    Fiedler J; Strauss G; Wannack M; Schwiebert S; Seidel K; Henning K; Klopocki E; Schmugge M; Gaedicke G; Schulze H
    Haematologica; 2012 Jan; 97(1):73-81. PubMed ID: 21933853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reticulated platelets as a marker of megakaryopoiesis in liver cirrhosis; relation to thrombopoietin and hepatocyte growth factor serum concentration.
    Panasiuk A; Prokopowicz D; Zak J; Panasiuk B
    Hepatogastroenterology; 2004; 51(58):1124-8. PubMed ID: 15239259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling.
    Lebois M; Dowling MR; Gangatirkar P; Hodgkin PD; Kile BT; Alexander WS; Josefsson EC
    J Thromb Haemost; 2016 Sep; 14(9):1882-7. PubMed ID: 27344013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal and pathological dynamics of platelets in humans.
    Langlois GP; Craig M; Humphries AR; Mackey MC; Mahaffy JM; Bélair J; Moulin T; Sinclair SR; Wang L
    J Math Biol; 2017 Dec; 75(6-7):1411-1462. PubMed ID: 28391511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation assays measuring platelet kinetics in bone marrow and peripheral blood. An overview.
    Louwes H; De Wolf JT; Houwerzijl E; Vellenga E
    Nucl Med Commun; 2002 Jun; 23(6):581-90. PubMed ID: 12029215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic change of cytokines in a patient with cyclic thrombocytopenia.
    Kimura F; Nakamura Y; Sato K; Wakimoto N; Kato T; Tahara T; Yamada M; Nagata N; Motoyoshi K
    Br J Haematol; 1996 Jul; 94(1):171-4. PubMed ID: 8757531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.
    Iraqi M; Perdomo J; Yan F; Choi PY; Chong BH
    Haematologica; 2015 May; 100(5):623-32. PubMed ID: 25682608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are there more tricks in the bag for treating thrombocytopenia?
    Leavitt AD
    J Clin Invest; 2010 Nov; 120(11):3807-10. PubMed ID: 20972327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human adipose tissue-derived stromal cells can differentiate into megakaryocytes and platelets by secreting endogenous thrombopoietin.
    Ono-Uruga Y; Tozawa K; Horiuchi T; Murata M; Okamoto S; Ikeda Y; Suda T; Matsubara Y
    J Thromb Haemost; 2016 Jun; 14(6):1285-97. PubMed ID: 26990635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Megakaryocyte modification of platelets in thrombocytopenia.
    Roweth HG; Parvin S; Machlus KR
    Curr Opin Hematol; 2018 Sep; 25(5):410-415. PubMed ID: 29985173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombopoietin production in a patient with chronic thrombocytopenia after plasma infusion.
    McDonald TP; Miura M; Koizumi S
    Thromb Res; 1985 May; 38(4):353-9. PubMed ID: 4012668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoietin: biology and potential clinical applications.
    Prow D; Vadhan-Raj S
    Oncology (Williston Park); 1998 Nov; 12(11):1597-604, 1607-8; discussion 1611-4. PubMed ID: 9834938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Milestones in understanding platelet production: a historical overview.
    Kuter DJ
    Br J Haematol; 2014 Apr; 165(2):248-58. PubMed ID: 24528208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets exposed to elevated levels of endogenous thrombopoietin in vivo have a reduced response to megakaryocyte growth and development factor in vitro.
    Nishiyama U; Morita H; Torii Y; Kuwaki T; Shimizu E; Akahori H; Kato T; Miyazaki H
    Thromb Haemost; 2001 Jan; 85(1):152-9. PubMed ID: 11204567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analyses of the small molecule thrombopoietin receptor agonist eltrombopag and thrombopoietin on in vitro platelet function.
    Erhardt JA; Erickson-Miller CL; Aivado M; Abboud M; Pillarisetti K; Toomey JR
    Exp Hematol; 2009 Sep; 37(9):1030-7. PubMed ID: 19631713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The physiological response of thrombopoietin (c-Mpl ligand) to thrombocytopenia in the rat.
    Yang C; Li YC; Kuter DJ
    Br J Haematol; 1999 May; 105(2):478-85. PubMed ID: 10233424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis.
    Nagata Y; Shozaki Y; Nagahisa H; Nagasawa T; Abe T; Todokoro K
    Thromb Haemost; 1997 May; 77(5):808-14. PubMed ID: 9184382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of thrombopoietin-derived peptides recognized by both cellular and humoral immunities in healthy donors and patients with thrombocytopenia.
    Takedatsu H; Yoshimoto K; Okamura T; Miyazaki H; Kuwaki T; Sata M; Itoh K
    Stem Cells; 2005 Aug; 23(7):975-82. PubMed ID: 16043461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contribution of isotope technics to the study of thrombocytopenias of central origin].
    Ardaillou N; Najean Y
    Nouv Rev Fr Hematol; 1973; 13(4):488-94. PubMed ID: 4271097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.